Viscoelastic Hydrogel Scaffolds for Spinal Cord Organoid Patterning
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for developing 3D organoids, such as spinal cord organoids, lack in vivo-like microenvironment for spatial cues and environmental stimulations, leading to inadequate patterning, reduced disease modeling accuracy, and impaired functional neuronal maturation.
Innovation Solution
A spinal cord model using a cell scaffold composed of methacrylated hyaluronic acid (HAMA) and dopamine-modified hyaluronic acid (HA-Cat) supports the culture of spinal cord spheroids or organoids, expressing ventral, dorsal, and interneuron markers, and can be co-cultured with blood vessel spheroids to form a blood-spinal cord barrier model.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If small molecules are used to induce neuronal cell differentiation in 2D culture, then conversion rate is improved, but spatial cues for 3D structure patterning are insufficient
Solution Approach 1:
The patent introduces a hydrogel scaffold as an intermediary material that provides both mechanical support and biochemical signaling cues. The hydrogel contains embedded morphogen gradients (such as retinoic acid) that diffuse through the matrix to provide spatial patterning information, bridging the gap between 2D high-conversion differentiation and 3D spatial organization.
Solution Approach 2:
The patent changes the physical and chemical parameters of the culture environment by using a hydrogel matrix with specific mechanical properties (elasticity, porosity) and biochemical composition. These parameter changes enable the hydrogel to provide both the conversion rate benefits of small molecule induction and the spatial patterning capabilities of 3D microenvironmental cues.
2Device complexity
If 3D organoids are cultured without in vivo-like microenvironment, then culture simplicity is maintained, but functional neuronal maturation is impaired
Solution Approach 1:
The patent applies local quality by creating region-specific zones within the hydrogel scaffold with different biochemical compositions and mechanical properties. Different areas of the hydrogel can be engineered to provide specific signaling cues (e.g., neurogenic factors in one region, glial factors in another) to promote localized neuronal maturation and functional specialization.
Solution Approach 2:
The patent uses composite materials by combining hydrogel matrix with embedded morphogen gradients, growth factors, and mechanical stimuli. This composite structure integrates multiple functional elements (structural support, biochemical signaling, mechanical cues) into a single culture system that mimics in vivo microenvironment without excessive complexity.
3Reliability
If environmental stimulations are provided in vitro, then functional maturation is improved, but model complexity increases
Solution Approach 1:
The patent implements self-service by designing the hydrogel scaffold to automatically provide environmental stimulations through its inherent properties. The hydrogel's mechanical properties, porosity, and embedded morphogen gradients work together to provide cues for neuronal maturation without requiring external intervention or complex control systems, reducing model complexity while maintaining functional maturation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The model provides a more in vivo-like environment for spinal cord organoids, enhancing patterning and functional maturation, improving disease modeling accuracy and enabling the screening of therapeutic agents.
Implementation Method 1
Viscoelastic hydrogel regulation of organoid patterning and vascularization
Implementation Method 2
a cell scaffold including methacrylated hyaluronic acid (HAMA) and dopamine-modified hyaluronic acid (HA-Cat)
Data Source
AI summary
Disclosed herein are spinal cord models including a cell scaffold including methacrylated hyaluronic acid (HAMA) and dopamine-modified hyaluronic acid (HA-Cat), and a spinal cord spheroid or organoid or a fragment thereof cultured on the cell scaffold. Said spinal cord spheroids or organoids or fragments thereof can be co-cultured with blood vessel spheroid organoids to form blood-spinal cord barrier models. Also disclosed herein are methods of making and using said models.